Stay updated on Nivolumab with Bevacizumab in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3. The previous v3.4.2 tag was removed.
    Difference
    0.1%
    Check dated 2026-03-11T23:46:36.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; Deleted older notice about funding/operation status (Revision: v3.4.1). These are administrative updates that do not affect trial content or how users interact with the page; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:07:53.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status, and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:26:05.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    These are minor UI/metadata updates: a glossary toggle was added, and labels such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' appeared, while the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:01:31.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Minor metadata update: the footer now shows Revision: v3.3.4, replacing Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:57:08.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Footer updates include Revision: v3.3.3 and the removal of HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T17:26:41.000Z thumbnail image

Stay in the know with updates to Nivolumab with Bevacizumab in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.